These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15122773)

  • 1. Hepatic adducts, circulating antibodies, and cytokine polymorphisms in patients with diclofenac hepatotoxicity.
    Aithal GP; Ramsay L; Daly AK; Sonchit N; Leathart JB; Alexander G; Kenna JG; Caldwell J; Day CP
    Hepatology; 2004 May; 39(5):1430-40. PubMed ID: 15122773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility to diclofenac-induced hepatotoxicity: contribution of UGT2B7, CYP2C8, and ABCC2 genotypes.
    Daly AK; Aithal GP; Leathart JB; Swainsbury RA; Dang TS; Day CP
    Gastroenterology; 2007 Jan; 132(1):272-81. PubMed ID: 17241877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of immune-related factors in diclofenac-induced acute liver injury in mice.
    Yano A; Higuchi S; Tsuneyama K; Fukami T; Nakajima M; Yokoi T
    Toxicology; 2012 Mar; 293(1-3):107-114. PubMed ID: 22285467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of polymorphism in CYP2C9 to genetic susceptibility to diclofenac-induced hepatitis.
    Aithal GP; Day CP; Leathart JB; Daly AK
    Pharmacogenetics; 2000 Aug; 10(6):511-8. PubMed ID: 10975605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of diclofenac and its metabolites in immune activation associated with acute hepatotoxicity in TgCYP3A4/hPXR-humanized mice.
    Jiang W; Dai T; Xie S; Ding L; Huang L; Dai R
    Int Immunopharmacol; 2020 Sep; 86():106723. PubMed ID: 32615451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen.
    Wade LT; Kenna JG; Caldwell J
    Chem Res Toxicol; 1997 May; 10(5):546-55. PubMed ID: 9168252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac.
    Pumford NR; Myers TG; Davila JC; Highet RJ; Pohl LR
    Chem Res Toxicol; 1993; 6(2):147-50. PubMed ID: 8477004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCR2 and CCR5 promote diclofenac-induced hepatotoxicity in mice.
    He Z; Wei G; Li N; Niu M; Gong S; Wu G; Wang T; Jiang Y; Chen P
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Mar; 392(3):287-297. PubMed ID: 30483860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of IL-10, IL-4 and TNF-alpha polymorphisms in drug-induced liver injury (DILI) and its outcome.
    Pachkoria K; Lucena MI; Crespo E; Ruiz-Cabello F; Lopez-Ortega S; Fernandez MA; Romero-Gomez M; Madrazo A; Durán JA; de Dios AM; Borraz Y; Navarro JM; Andrade RJ;
    J Hepatol; 2008 Jul; 49(1):107-14. PubMed ID: 18485518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of drug-independent stress factors in liver injury associated with diclofenac intake.
    Ramm S; Mally A
    Toxicology; 2013 Oct; 312():83-96. PubMed ID: 23939143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity.
    Aithal GP
    Expert Opin Drug Saf; 2004 Nov; 3(6):519-23. PubMed ID: 15500411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 polymorphisms and susceptibility to ARV associated hepatotoxicity.
    Singh H; Samani D; Nain S; Dhole TN
    Microb Pathog; 2019 Aug; 133():103544. PubMed ID: 31121270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.
    Aithal GP; Day CP
    Clin Liver Dis; 2007 Aug; 11(3):563-75, vi-vii. PubMed ID: 17723920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 and interleukin-10 polymorphisms and antituberculosis drug-induced hepatotoxicity in Chinese population.
    Wang J; Chen R; Tang S; Lv X; Wu S; Zhang Y; Yang Z; Xia Y; Chen D; Zhan S
    J Clin Pharm Ther; 2015 Apr; 40(2):186-91. PubMed ID: 25308608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NSAID-induced hepatotoxicity: aceclofenac and diclofenac].
    Zaragoza Marcet A; Alfonso Moreno V; Roig Catalá E
    Rev Esp Enferm Dig; 1995 Jun; 87(6):472-5. PubMed ID: 7612373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.
    Singh H; Nambiar N; Samani D; Gangakhedkar RR
    Curr Mol Med; 2019; 19(3):206-215. PubMed ID: 30973108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-4/interleukin-4 receptor gene polymorphisms in hand osteoarthritis.
    Vargiolu M; Silvestri T; Bonora E; Dolzani P; Pulsatelli L; Addimanda O; Mancarella L; Punzi L; Fioravanti A; Facchini A; Romeo G; Meliconi R
    Osteoarthritis Cartilage; 2010 Jun; 18(6):810-6. PubMed ID: 20219689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical detection of protein adducts in cultured human hepatocytes exposed to diclofenac.
    Gil ML; Ramirez MC; Terencio MC; Castell JV
    Biochim Biophys Acta; 1995 Dec; 1272(3):140-6. PubMed ID: 8541344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between genes encoding components of the IL-4/IL-4 receptor pathway and dermatitis in children.
    Hussein YM; Shalaby SM; Nassar A; Alzahrani SS; Alharbi AS; Nouh M
    Gene; 2014 Jul; 545(2):276-81. PubMed ID: 24742632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of UGT2B7*2 and CYP2C8*4 polymorphisms on diclofenac metabolism.
    Lazarska KE; Dekker SJ; Vermeulen NPE; Commandeur JNM
    Toxicol Lett; 2018 Mar; 284():70-78. PubMed ID: 29203276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.